Amylyx Pharmaceuticals, a company developing a innovative therapeutic for amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease), recently announced that former Biogen CEO Walter Gilbert, Ph.D and Nobel Laureate, will join Amylyx’s board of directors. “Dr. Gilbert brings an enormous breadth of experience as a scientist, biotech founder,…
CIRM has funded the ALS Disease Team led by scientists at UC San Diego, The Salk Institute, and Life Technologies Corporation, who aim to bring a human embryonic stem cell-based ALS therapy to clinical trials within four years. Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease, is…
Motor neurone disease (MND) is a terminal disease and is physically and emotionally devastating for both the sufferer and the carer. In this Tobin Brothers exclusive documentary, Lisa Morgan, wife of actor Richard Morgan, and former AFL coach Neale Daniher talked to Michael Lynch about their confronting experiences with…
Researchers have identified an essential protein, Pur-alpha, for motor neuron cells’ mechanisms of defense against external stress and degeneration and also as a potential new therapeutic target for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease). The research paper, “Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates…
Meet Bernardo Pinto Coelho. In this video, he talks about the five rules which have helped him improved his life with ALS. Learn more about ALS here: https://bit.ly/ALSNewsToday…
“This video explores a highly compelling cause of ALS, how it may have given Lou Gehrig himself ALS, and how the ALS association is reacting to it.” Learn more about ALS: https://bit.ly/ALSNewsToday…
A recent review summarized the effects of immune system dysregulation and neuroinflammation in the regulation of critical pathways associated with depression and other brain disorders, including amyotrophic lateral sclerosis (ALS). The researchers specifically focused on extracellular vesicles (EVs) as potential biomarkers and drug delivery vehicles. The review, “Neuroinflammation and Depression: Microglia Activation, Extracellular Microvesicles…
In this ALS Association video, learn more about our military heroes who were being diagnosed and dying from Lou Gehrig’s disease in the years following the operation Desert Storm in 1981. Learn more about ALS here: https://bit.ly/ALSNewsToday…
Read the Articles Here: ALS Stem Cell Therapy Seen to Benefit Patients in First Round of Clinical Tests ALS Patients Show Increased Response to Specific Receptor in Spinal Cord ALS Severity, Duration May Be Linked to Glutamate Toxicity …
Cytokinetics Inc. has presented its Vision 2020: Empowering Our Future – an initiative designed to expand the company’s pipeline until 2020, as well as advance its muscle biology-directed drug candidates toward late-stage development and marketing strategies, to tackle the unmet medical needs of people living with impaired muscle…
Get regular updates to your inbox.
